The 13th London Myology Forum is taking place on the Wednesday 4th June 2025 at the Elvin Hall, UCL IOE, 20 Bedford Way, WC1H 0AL.
Free event, registration required by contacting Jane at [email protected]
5 Partners & 1 Associated partner of #EFFecT are present at SMOT (Synergistic Meeting on Oligonucleotide Therapeutics) celebrating #rarediseaseday.
We are looking forward to start working together! Remember we are recruiting until March 15!!!📢
https://t.co/WW8XBemxqP
@SO_genetherapy This is a great opportunity working as a senior fellow in the Dubowitz Neuromuscular Centre under Professor Francesco Muntoni's mentorship!
I'm excited to share that I have started a new role as a Research Fellow at @UCLchildhealth where I'll be working in Prof. @lab_zhou research group developing cell-targeting peptides for nucleic acid delivery.
We are delighted to announce today the inaugural 2024 Oxford-Harrington Rare Disease Scholars, selected from a large number of outstanding proposals from the US, UK and Canada, to develop breakthrough treatments for #rarediseases. Congratulations to the ten Scholars!
Oxford-Harrington is delighted to welcome Lord Cameron @David_Cameron as Chair of our Advisory Council, leading our international efforts to drive the Centre’s mission of delivering 40 new therapies for rare diseases into clinical trials over the coming decade.
Huge congratulations to Pambos, Konstantina @konstantina_tet and Ivan, our young talents who have won the best presentation Prizes from the World Muscle Society International Congress in Prague! Very proud of you 👏🎉 @DNP_ICH @GGM_ICH
📢
Calling all UK neuromuscular researchers and friends of @MDUK_News at #WMS2024 – pop along to stand 32 and chat to John about all things research and our grant round https://t.co/8Meszpe9y8
👥🗣️👩🦼💡🧬🔬💊🩺🧪
An exciting Research Assistant position in the Zhou Lab on RNA drug development. here is the applicaiton link: https://t.co/ToERAl07Rt
Application deadline 20th Oct 2024. Please do help circulate it.
Really inspiring and thought provoking discussions around the patient, disease and variant selection process for rare disease RNA therapy development @UpNAT_node
@OHRareDisease@UpNAT_node@RDRUKHub@aliceedavidson Great to have everyone together seeking synergy and working towards the same goal for rare disease in the UK! Thank you for attending and joining the discussion.
Today we are in London at the Inaugural Symposium of the UK Platform for Nucleic Acid Therapies @UpNAT_node@RDRUKHub which set to be an invaluable resource for the #raredisease community. Introduction by @lab_zhou the Director of UPNAT